skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors

Kelsey, Chris R., M.D ; Horwitz, Mitchell E., M.D ; Chino, Junzo P., M.D ; Craciunescu, Oana, Ph.D ; Steffey, Beverly, M.S ; Folz, Rodney J., M.D. Ph.D ; Chao, Nelson J., M.D ; Rizzieri, David A., M.D ; Marks, Lawrence B., M.D

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.812-818 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?
Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?

Rizzieri, David

Critical reviews in oncology/hematology, 2016-09, Vol.105, p.5-17 [Periódico revisado por pares]

Netherlands: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
3
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

ARMAND, Philippe ; NAGLER, Arnon ; FAY, Joseph W ; RIZZIERI, David A ; HOSING, Chitra M ; BALL, Edward D ; UBERTI, Joseph P ; LAZARUS, Hillard M ; MAPARA, Markus Y ; GREGORY, Stephanie A ; TIMMERMAN, John M ; ANDORSKY, David ; WELLER, Edie A ; OR, Reuven ; WALLER, Edmund K ; ROTEM-YEHUDAR, Rinat ; GORDON, Leo I ; DEVINE, Steven M ; AVIGAN, David E ; CHEN, Yi-Bin ; KAMINSKI, Mark S ; KENT HOLLAND, H ; WINTER, Jane N ; MASON, James R

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

DUVAL, Michel ; KLEIN, John P ; KEATING, Armand ; LAZARUS, Hillard M ; LITZOW, Mark R ; MARKS, David I ; MAZIARZ, Richard T ; RIZZIERI, David A ; SCHILLER, Gary ; SCHULTZ, Kirk R ; TALLMAN, Martin S ; WEISDORF, Daniel ; WENSHENG HE ; CAHN, Jean-Yves ; CAIRO, Mitchell ; CAMITTA, Bruce M ; KAMBLE, Rammurti ; COPELAN, Edward ; DE LIMA, Marcos ; GUPTA, Vikas

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3730-3738 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Pemmaraju, Naveen ; Sweet, Kendra L ; Stein, Anthony S ; Wang, Eunice S ; Rizzieri, David A ; Vasu, Sumithira ; Rosenblat, Todd L ; Brooks, Christopher L ; Habboubi, Nassir ; Mughal, Tariq I ; Kantarjian, Hagop ; Konopleva, Marina ; Lane, Andrew A

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3032-3036 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
6
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality

FENSKE, Timothy S ; ZHANG, Mei-Jie ; HOLMBERG, Leona A ; INWARDS, David J ; LAZARUS, Hillard M ; MAZIARZ, Richard T ; MUNKER, Reinhold ; PERALES, Miguel-Angel ; RIZZIERI, David A ; SCHOUTEN, Harry C ; SMITH, Sonali M ; WALLER, Edmund K ; CARRERAS, Jeanette ; WIRK, Baldeep M ; LAPORT, Ginna G ; MALONEY, David G ; MONTOTO, Silvia ; HARI, Parameswaran N ; AYALA, Ernesto ; BURNS, Linda J ; CASHEN, Amanda ; COSTA, Luciano J ; FREYTES, César O ; GALE, Robert P ; HAMADANI, Mehdi

Journal of clinical oncology, 2014-02, Vol.32 (4), p.273-281 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

FADERL, Stefan ; WETZLER, Meir ; MARIS, Michael ; KOVACSOVICS, Tibor ; GOLDBERG, Stuart ; SEITER, Karen ; HARI, Parameswaran ; GREINER, Jochen ; VEY, Norbert ; RECHER, Christian ; RAVANDI, Farhad ; WANG, Eunice S ; RIZZIERI, David ; VASCONCELLES, Michael ; HUEBNER, Dirk ; KANTARJIAN, Hagop M ; SCHILLER, Gary ; JAGASIA, Madan ; STUART, Robert ; GANGULY, Siddhartha ; AVIGAN, David ; CRAIG, Michael ; COLLINS, Robert

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2492-2499 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Age-Specific Differences in Oncogenic Pathway Dysregulation and Anthracycline Sensitivity in Patients With Acute Myeloid Leukemia
Age-Specific Differences in Oncogenic Pathway Dysregulation and Anthracycline Sensitivity in Patients With Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Age-Specific Differences in Oncogenic Pathway Dysregulation and Anthracycline Sensitivity in Patients With Acute Myeloid Leukemia

RAO, Arati V ; VALK, Peter J. M ; POTTI, Anil ; LÖWENBERG, Bob ; METZELER, Klaus H ; ACHARYA, Chaitanya R ; TUCHMAN, Sascha A ; STEVENSON, Marvaretta M ; RIZZIERI, David A ; DELWEL, Ruud ; BUSKE, Christian ; BOHLANDER, Stefan K

Journal of clinical oncology, 2009-11, Vol.27 (33), p.5580-5586 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Shaffer, Brian C ; Ahn, Kwang Woo ; Hu, Zhen-Huan ; Nishihori, Taiga ; Malone, Adriana K ; Valcárcel, David ; Grunwald, Michael R ; Bacher, Ulrike ; Hamilton, Betty ; Kharfan-Dabaja, Mohamed A ; Saad, Ayman ; Cutler, Corey ; Warlick, Erica ; Reshef, Ran ; Wirk, Baldeep Mona ; Sabloff, Mitchell ; Fasan, Omotayo ; Gerds, Aaron ; Marks, David ; Olsson, Richard ; Wood, William Allen ; Costa, Luciano J ; Miller, Alan M ; Cortes, Jorge ; Daly, Andrew ; Kindwall-Keller, Tamila L ; Kamble, Rammurti ; Rizzieri, David A ; Cahn, Jean-Yves ; Gale, Robert Peter ; William, Basem ; Litzow, Mark ; Wiernik, Peter H ; Liesveld, Jane ; Savani, Bipin N ; Vij, Ravi ; Ustun, Celalettin ; Copelan, Edward ; Popat, Uday ; Kalaycio, Matt ; Maziarz, Richard ; Alyea, Edwin ; Sobecks, Ron ; Pavletic, Steven ; Tallman, Martin ; Saber, Wael

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1864-1871 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial
Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial

Craciunescu, Oana I., Ph.D ; Steffey, Beverly A., M.S ; Kelsey, Chris R., M.D ; Larrier, Nicole A., M.D ; Paarz-Largay, Cathy J., PA.-C., M.S ; Prosnitz, Robert G., M.D ; Chao, Nelson, M.D., M.B.A ; Chute, John, M.D ; Gasparetto, Cristina, M.D ; Horwitz, Mitchell, M.D ; Long, Gwynn, M.D ; Rizzieri, David, M.D ; Sullivan, Keith M., M.D

International journal of radiation oncology, biology, physics, 2011-03, Vol.79 (4), p.1248-1255 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (323)

Data de Publicação 

De até
Refinar
  1. Antes de2004  (5)
  2. 2004Até2008  (30)
  3. 2009Até2013  (129)
  4. 2014Até2019  (110)
  5. Após 2019  (69)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (57)
  2. Polonês  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.